Article Text

Download PDFPDF
Authors' response
  1. Salman Waqar1,
  2. Salem Murjaneh1,
  3. Julia E Hale2,
  4. Maan Kasmiya1,
  5. John Jacob1,
  6. Anthony G Quinn1
  1. 1West of England Eye Unit, Exeter, UK
  2. 2Bristol Eye Hospital, Bristol, UK
  1. Correspondence to Anthony G Quinn, Consultant Ophthalmologist, West of England Eye Unit, Royal Devon & Exeter Hospital, Exeter, UK; anthony.quinn{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

We would like to thank Bellini et al for their letter and also congratulate them on their very low endophthalmitis rate. We would, however, like to reiterate that the European Society of Cataract and Refractive Surgeons (ESCRS) study on prophylaxis of postoperative endophthalmitis after cataract surgery1 currently represents the largest evidence base for this issue. This partially masked randomised placebo-controlled multinational clinical study sought to evaluate prospectively the prophylactic effect of intracameral cefuroxime injection and/or perioperative levofloxacin (third-generation fluoroquinolone) eye-drops on the incidence of endophthalmitis after phacoemulsification cataract surgery. This study, which involved 13 698 patients, …

View Full Text


  • Linked article: 205039.

  • Competing interests None.

  • Provenance and peer review Commissioned; not externally peer reviewed.

Linked Articles